Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ADAMTS7
REST API REST API
Homo sapiens
ADAMTS7 is differentially expressed in 88 experiments: 38 organism parts: lung, endometrium, ... (36 more);, 42 disease states: normal, Huntington's disease, ... (40 more);, 26 cell types 131 cell lines 4 compound treatments and 33 other conditions.
Synonyms DKFZp434H204, ADAM-TS7
Orthologs Adamts7 (Mus musculus)   ADAMTS7 (Gallus gallus)   ADAMTS7 (Bos taurus)   CG4096 (Drosophila melanogaster)   ENSCING00000008960 (Ciona intestinalis)   Adamts7 (Rattus norvegicus)   adamts7 (Xenopus laevis)   ADAMTS7 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term metalloendopeptidase activity, metallopeptidase activity, peptidase activity, proteinaceous extracellular matrix, metal ion binding, extracellular region, proteolysis, cell surface, extracellular matrix, zinc ion binding
InterPro Term Peptidase_M12B_ADAM-TS, Peptidase_M12B_N, PLAC, ADAM_spacer1, Thrombospondin_1_rpt, Peptidase_M12B
UniProt Accession Q9UKP4, A8MQ00, E7EP58
Search EB-eye ENSG00000136378
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-803, E-GEOD-18105, E-MTAB-69, ... (10 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-19480, E-MEXP-903, E-MTAB-37, E-GEOD-5823, ... (13 experiments)

Factor Value U/D Experiments
HDMYZ
1
E-MTAB-37
NCIH1155
1
E-MTAB-37
OE19
1
E-MTAB-37
SW1116
1
E-MTAB-37
SW1463
1
E-MTAB-37
T84
1
E-MTAB-37
125 more value(s).


Cell type

studied in E-AFMX-5, E-GEOD-18811, E-GEOD-20033, E-TABM-130, E-GEOD-20677, ... (13 experiments)

Factor Value U/D Experiments
spermatocyte
1
E-TABM-130
spermatid
1
E-TABM-130
memory B cell
1
E-TABM-702
cancer cell culture
1
E-GEOD-14990
naive B cell
1
E-TABM-702
Embryonic Kidney cell
1
E-GEOD-20677
20 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-3860, E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, ... (23 experiments)

Factor Value U/D Experiments
normospermic
1
E-GEOD-6872
uterine fibroid
1
E-GEOD-7307
HCL (Hairy Cell Leukemia)
1
E-GEOD-16455
acute HIV-1 infection
1
E-GEOD-16363
Wilms tumor
1
E-MTAB-37
FKRP mutation
1
E-GEOD-3307
36 more value(s).


Compound treatment

studied in E-GEOD-15205, E-GEOD-5741, E-GEOD-7307

Factor Value U/D Experiments
TNF
1
E-GEOD-15205
unknown
1
E-GEOD-7307
ox-LDL
1
E-GEOD-5741
TGF
1
E-GEOD-15205


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
tunicamycin
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-GEOD-4667

Disease staging
studied in E-GEOD-19743, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-GEOD-3494, E-GEOD-17476, E-TABM-321

Growth condition
studied in E-GEOD-13073, E-GEOD-20504, E-GEOD-9764

Histology
studied in E-GEOD-21653, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-666, E-GEOD-19519, E-GEOD-6919, ... (14 experiments)

Infection
studied in E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445

pt
studied in E-GEOD-21653

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-7307

Subtype
studied in E-GEOD-24283

Treatment
studied in E-GEOD-19246

Tumor grading
studied in E-GEOD-4922

Processing time: 0.251 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM